west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "黄建安" 13 results
  • Biochemical parameters of prognostication in acute lung injury/acute respiratory distress syndrome

    急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)是指由心源性以外的各种肺内外致病因素所导致的急性进行性缺氧性呼吸衰竭,它们具有性质相同的病理生理改变,严重的ALI或ALI的最终严重阶段被定义为ARDS,临床表现以呼吸窘迫、顽固性低氧血症和非心源性肺水肿为特征,采用常规的治疗难以纠正其低氧血症,死亡率高达60%。目前,有关ALI/ARDS的研究取得较多进展,其中,能有效评估ALI病情和预测死亡率的临床参数和生化指标一直是研究热点。

    Release date:2016-09-14 11:53 Export PDF Favorites Scan
  • 自噬在呼吸系统的研究现状

    Release date:2017-11-23 02:56 Export PDF Favorites Scan
  • 靶肺去神经疗法在慢性阻塞性肺疾病中的应用进展

    Release date: Export PDF Favorites Scan
  • Clinical diagnosis and treatment of severe adenovirus pneumonia with ARDS: three cases report and literature review

    ObjectiveTo explore the diagnosis and treatment of severe adenovirus pneumonia patients with severe acute respiratory distress syndrome (ARDS) in a short time and reduce the complications after rehabilitation. MethodsThe clinical data, laboratory results, treatment process and imaging outcomes of three severe community-acquired adenovirus pneumonia patients with normal immune function were analyzed. ResultsAll the three patients developed ARDS in a very short time. In the early stage, alveolar lavage fluid obtained by fiberoptic bronchoscopy was taken for macrogenomic second-generation sequencing (mNGS), adenovirus was detected and antiviral drugs were immediately used. The first two patients received cidofovir antiviral therapy and the third patient received ribavirin antiviral therapy. All three patients received very high respiratory support, of which the first two received extracorporeal membrane oxygenation treatment. The lungs of all three patients recovered well after treatment. ConclusionsThe diagnosis and treatment of severe adenovirus pneumonia is still based on individualized symptomatic support, immune regulation and treatment of complications. mNGS can help diagnose and direct treatment of adenovirus pneumonia as early as possible, which is beneficial to reduce complications and improve survival rate.

    Release date: Export PDF Favorites Scan
  • Application of Metagenomic Next-Generation Sequencing Combined with Omadacycline in Refractory Mycoplasma Pneumoniae Pneumonia: Four Cases Report and Literature Review

    ObjectiveTo explore the application and clinical value of metagenomic next-generation sequencing (mNGS) combined with Omadacycline in the treatment of Refractory Mycoplasma pneumoniae pneumonia (RMPP).MethodsThe clinical data, relevant laboratory results, diagnosis and treatment process, and imaging outcomes of four patients diagnosed with Mycoplasma pneumoniae pneumonia through mNGS were analyzed. ResultsThe clinical symptoms at onset in all four patients were consistent with Mycoplasma pneumoniae pneumonia. After conventional treatment with macrolides, tetracyclines, or quinolone antibiotics, the symptoms showed no significant improvement, and there was a trend of radiological worsening. Following the confirmation of Mycoplasma pneumoniae infection through mNGS of bronchoalveolar lavage fluid, and due to various reasons preventing the use of the aforementioned drugs, omadacycline was ultimately chosen for treatment. Radiological improvements were observed in all cases, leading to a good prognosis and discharge. ConclusionsFor pneumonia cases where the infectious pathogen cannot be identified and conventional treatment has failed, mNGS can be utilized for early and accurate diagnosis. In cases of RMPP, Omadacycline can be employed as an alternative treatment to prevent delays in care and reduce the risk of complications.

    Release date:2025-06-25 01:52 Export PDF Favorites Scan
  • Lymphoma manifested firstly as symptoms in respiratory system: nine cases report and literature review

    Objective To explore the clinical characteristics of patients with lymphoma firstly manifested as symptoms in respiratory system. Methods The clinical data of 9 patients with lymphoma were analyzed retrospectively and discussed with literature review. Results There were 7 males and 2 females with an average age of 48.2 years and a median disease course of 20 days. All patients were diagnosed by pathology while specimens were obtained by cervical lymph node biopsies in 2 cases, by CT-guided percutaneous lung biopsies in 2 cases, by bronchoscope mucosal biopsies in 2 cases, by transbronchial needle aspiration biopsies in 1 case, by thoracoscope lung biopsies in 1 case, and by ascites cell block inspection in 1 case. The main symptoms were cough (7/9), expectoration (3/9), fever (3/9) and wheeze (2/9). Chest CT showed tumors (3/9, multiple in 1 case), enlarged mediastinal lymph nodes (6/9), enlarged hilar lymph nodes (3/9), pulmonary consolidation (3/9), pleural effusion (6/9, bilateral in 3 cases), pleural thickening (2/9), pulmonary atelectasis (2/9), patchy shadow (7/9), pericardial effusion (1/9). Laboratory examination demonstrated elevated cancer antigen 125 (CA125) in 7 cases while elevated lactic acid dehydrogenase (LDH) in 4 cases. One patient died during hospitalization in the respiratory department, 1 patient auto-discharged without further treatment, 1 patient died in follow-up period. Five patients remain alive up to now. Conclusions The symptoms of patients with lymphoma are atypical while the chest radiological findings are varied. CA125 and LDH play important role in evaluating disease and predicting prognosis in patients with lymphoma.

    Release date:2017-04-01 08:56 Export PDF Favorites Scan
  • 免疫检查点抑制剂治疗合并乙型肝炎或丙型肝炎的晚期非小细胞肺癌的安全性及疗效分析

    目的 探讨合并乙型肝炎或丙型肝炎的晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)免疫检查点抑制剂(immune checkpoint inhibitors,ICIs)治疗的安全性和疗效。方法 回顾性分析5例合并乙型肝炎或丙型肝炎的NSCLC,观察谷丙转氨酶(alanine aminotransferase,ALT)水平、病毒载量和总生存期。结果 1例活动性乙型肝炎和1例活动性丙型肝炎启动ICIs治疗时,ALT升高,加用抗病毒和保肝治疗,ALT即恢复正常。2例活动性和1例慢性乙型肝炎ICIs治疗,ALT持续正常水平。2例完全缓解,3例部分缓解,目前死亡2例,最长总生存期35.7个月,其余3例仍在随访中。结论 乙型肝炎或丙型肝炎不影响ICIs在NSCLC中的治疗地位,包括在部分NSCLC的一线治疗,全程监测肝功能和病毒拷贝数,推荐联合抗病毒治疗(特别对合并乙型肝炎),个体化调整抗病毒时机及疗程。

    Release date: Export PDF Favorites Scan
  • The clinical analysis of 160 immunocompromised hosts with septicaemia

    Objective To explore the pathogens and clinical features of immunocompromised hosts with septicaemia.Methods The data including underlying diseases, peripheral blood granulocyte count, temperature at blood sampling, management and prognosis)of 160 immunocompromised hosts with septicaemia were analyzed retrospectively.Results 8 patients had twice septicaemia in hospital stay and 3 patients had plural pathogenic septicaemia.171 strains of microorganisms were isolated from blood cultured of 160 septic immuno- compromised hosts in which 156 strains (91.2%) were bacteria, 37 strains(21.6%) were gram positive cocci, 6 strains(3.5%) were gram positive bacilli, 113 strains (66.1%) were gram negative bacilli and 15 strains (8.8%) were fungi. Staphylococcus spp (17 strains) and Streptococcus spp (14 strains) were the predominant pathogens among gram positive cocci and Corynebacteria (5 strains ) were the main pathogen in gram positive bacilli while Escherichia coli (60 strains), Klebsiella pneumoniae (20 strains) and Pseudomonas aeruginosa (15 strains) were the most common bacteria in gram negative bacilli. There were 12 strains of Staphylococcus aureus among the 17 strains of Staphylococcus spp, all of them were methicillin sensitive (MSSA). 17 strains of Escherichia coli, 2 strains of Klebsiella pneumoniae and 1 strain of Klebsiella oxytoca produced ESBLs. Candida was the only pathogens of fungemia in this study in which 4 strains of Candida albicans and 11 strains of non-albicans Candida were detected. There were 120 patients(75%) with granulocytopeniain which 103 patients were agranulocytosis. 70% of the 160 paitents had hyperpyrexia. All patients received broad spectrum antibiotics therapy in the study while 58.8% received antifungal drugs at the same time. 20 patients died of septicaemia and 19 patients gave up therapy because of their conditions deteriorated.The overall improvement rate were 75.6%. Conclusions Bacteria are the main pathogens in septicaemia of immunocom- promised host and fungemia is increasing in recent years.Agranulocytosis is a risk factor of septicaemia in immunocompromised hosts. Hyperpyrexia is one of characteristic signs of these patients.

    Release date:2016-09-14 11:52 Export PDF Favorites Scan
  • Clinical Significance of CD4+CD25highCD127low Regulatory T Cells and Cytokines Detected in COPD Patients with Pulmonary Hypertension

    ObjectiveTo investigate the expression of CD4+CD25highCD127lowTreg (Treg) and related cytokines in peripheral blood of COPD patients with pulmonary hypertension and explore its clinical significance. MethodsPeripheral blood lymphocytes and serum were collected from 65 COPD patients with chronic pulmonary hypertension (the CPH group) and 20 COPD patients with normal pulmonary artery pressure (the control group). Flow cytometry was used to detect the Treg/CD4+ T cells and calculate its ratio, enzyme-linked immunosorbent assay was used to detect the serum contents of interleukin (IL)-6,IL-10 and tumor necrosis factor α (TNF-α). ResultsTreg can be detected in the peripheral blood of patients of COPD with or without PH, however, the Treg ratio in the CPH group was significantly lower than that in the control group [(7.41±1.12)% vs. (9.04±2.11)%, P<0.05]. Compared with the control group, the IL-10 level was significantly lower [(4.47±0.88)pg/mL vs. (5.18±0.26)pg/mL], while IL-6and TNF-α contents were significantly higher in the CPH group [(7.49±0.95)pg/mL vs. (6.76±0.35)pg/mL, (28.61±9.16)pg/mL vs. (19.64±4.85)pg/mL, P<0.05]. There was a positive correlation between Treg ratio and serum IL-10 level (r=0.41, P<0.05), and negative correlation between Treg ratio and TNF-α or IL-6 contents (r=0.45 or 0.37,P<0.05). The Treg ratio of the patients with severe pulmonary hypertension was lower than that in the patients with mild pulmonary hypertension [(7.42±1.03)% vs. (10.47±2.55)%,P<0.05). ConclusionsContents of Treg and IL-10 decrease while IL-6 and TNF-α increase in peripheral blood of COPD patients with pulmonary hypertension. It suggests that Treg cells and related cytokines may involve in the pathogenesis and progression of CPH. Treg may becomea potential biological prognosis indicator and treatment target of CPH in the future.

    Release date: Export PDF Favorites Scan
  • OX40/OX40L共刺激信号分子在支气管哮喘中的应用前景

    Release date:2016-10-10 10:33 Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content